🇺🇸 FDA
Patent

US 12173061

Compositions and methods for treatment of chronic lung diseases

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 12173061 (Compositions and methods for treatment of chronic lung diseases) held by The Board of Regents of the University of Texas System expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K38/177, A61K38/179